Vitamin D and cancer

Authors

  • Alberto Muñoz Terol

Keywords:

Vitamin D, cancer, gene expression

Abstract

Vitamin D, particularly its metabolite 1a, 25-dihydroxyvi- tamin D3 (1a,25(OH)2D3, calcitriol), is a main regulator of gene expression. 1a,25(OH)2D3 modulates the transcription rate of hundreds of genes and the activity of several enzymes and signalling pathways. A series of novel effects recently described make of 1a,25(OH)2D3 an attractive subject of study.

Downloads

Download data is not yet available.

References

Carsten, C. and Campbell, M.J. Vitamin D receptor signaling mechanisms: integrated actions of a well-defined transcription factor. Steroids, 78: 127-136, 2013.

Giovanucci E. Epidemiology of vitamin D and colorectal cancer. Anticancer Agents Med Chem, 13: 11- 19, 2013.

Deeb et al. Vitamin D signalling pathways in cancer: potential for anticancer therapeutics. Nat Rev Cancer, 7: 684-700, 2007.

Lazzeroni et al. Vitamin D supplementation and cancer: review of randomized controlled trials. Anti- cancer Agents Med Chem, 13: 118-125, 2013.

Pálmer et al. Vitamin D3 promotes the differentiation of colon carcinoma cells by the induction of E- cadherin and the inhibition of b-catenin signaling J Cell Biol, 154: 369-387, 2001.

Pereira et al. Vitamin D and colon cancer. Endocr-Rel Cancer, 19: R51-71, 2012.

Pálmer et al. The transcription factor SNAIL represses vitamin D receptor expression and responsive- ness in human colon cancer. Nat Med, 10: 917-919, 2004

Downloads

Published

2013-10-20

Dimensions

PlumX